GlassScriptPhysician profile
Erin Sieber
NPI 1275042509
$333,881.48
in general payments reported to CMS, 2019-2025
10 companies · $88K in 2025
The $88K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $718 · 2022: $45K · 2023: $100K · 2024: $100K · 2025: $88K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $275K · Travel and Lodging: $8,721 · Food and Beverage: $4,670 · Education: $57.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $275,165.00 |
| Travel and Lodging | $8,720.61 |
| Food and Beverage | $4,670.18 |
| Education | $57.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $288,589.39 | 2021-2025 | |
| Allergan, INC. | $44,741.55 | 2021-2022 | |
| Galderma Laboratories, L.P. | $278.87 | 2021-2024 | |
| Acessa Health INC. | $112.02 | 2021 | |
| Therapeuticsmd, INC. | $46.24 | 2021-2022 | |
| Coopersurgical, INC. | $38.79 | 2022 | |
| Organon LLC | $25.00 | 2021 | |
| Aspira Women'S Health INC | $19.86 | 2022 | |
| Dysis Medical, INC. | $18.37 | 2022 | |
| Avion Pharmaceuticals | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Sieber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.